Join to View Full Profile
20 York StYale-New Haven HospitalNew Haven, CT 06510
Phone+1 203-200-4363
Fax+1 203-785-4116
Dr. Parker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Terri Parker is an oncologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. She received her medical degree from St. George's University School of Medicine and has been in practice 12 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, and multiple myeloma.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Uconn School Of Medicine2008 - 2009- University of ConnecticutResidency, Internal Medicine, 2005 - 2008
St. George's University School of MedicineClass of 2005
Certifications & Licensure
CT State Medical License 2008 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma
- Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Start of enrollment: 2013 Dec 06
- An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma Start of enrollment: 2016 Aug 10
Publications & Presentations
PubMed
- Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.Cameron J Hunter, Wei Cheng, Jan Philipp Bewersdorf, Prajwal Boddu, Sabrina Browning
Leukemia & Lymphoma. 2026-01-01 - 1 citationsIsatuximab for relapsed and/or refractory AL amyloidosis: results of a prospective phase 2 trial (SWOG S1702).Terri L Parker, Adam Rosenthal, Vaishali Sanchorawala, Heather J Landau, Erica L Campagnaro
Blood. 2025-11-20 - 1 citationsTeclistamabB-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy in multiple myeloma: a comparative effectiveness analysis.Junmin Song, Cho-Han Chiang, Stepan Esagian, Gagi Kim, Kuan-Yu Chi
Haematologica. 2025-10-01
Abstracts/Posters
- Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...Terri L Parker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center ExperienceTerri L Parker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cutaneous toxicity of pralatrexate in cutaneous and peripheral T-cell lymphomaParker TL, Barbarotta L, Girardi M, and Foss F., American Society of Hematology Annual Meeting, Atlanta, GA, 12/2012
Committees
- Member, Scientific Protocol Review Committee at Smilow Cancer Hospital 2015 - Present
- Member, Laboratory Formulary Committee at Yale New Haven Hospital 2014 - Present
- Member, Smilow Ambulatory Care Committee 2013 - Present
- Member, Transfusion and Tissue Banking Committee at Yale New Haven Hospital 2013 - Present
- Member, Faculty Advisory Committee at Yale School of Medicine 2015 - 2017
Professional Memberships
- Member
- Member
- Member
- International Society of AmyloidosisMember
- International Myeloma SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
